{
    "nctId": "NCT05858398",
    "briefTitle": "Influence of Body Composition on Chemotherapy Outcomes in Localized Breast Cancer",
    "officialTitle": "Influence of Body Composition, Total Body Fat and Body Mass Index on the Pharmacokinetics of Docetaxel in Localized Breast Cancer",
    "overallStatus": "NOT_YET_RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "OTHER",
    "enrollmentCount": 48,
    "primaryOutcomeMeasure": "Comparison of docetaxel area under courb between obese and lean patients",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Woman older than\n* Early breast cancer\n* CT-scan of less than 3 months, including L3 level\n* Indication of docetaxel at 100 mg/m\u00b2 as adjuvant CT\n\nExclusion Criteria:\n\n* HER2 amplified or triple negative tumors\n* Pregnant or breastfeeding women\n* Patients under guardianship or curatorship\n* Concomitant administration of another cytotoxic drug or targeted therapy\n* Psychosocial disorder\n* Administration of another cytotoxic drug or targeted therapy within 20 days prior to blood collection",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}